Profile
| Metric | Value |
|---|---|
| Full Name | ABIVAX Société Anonyme |
| Ticker | NASDAQ: ABVX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | France |
| IPO | |
| Indexes | Not included |
| Website | abivax.com |
| Employees | 69 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $123.63 | |
| Price, 1D Change | +3.02% | |
| Market Cap | $10B | |
| - | ||
| PE Ratio | - | |
| Beta | 2.25 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$3.02 | |
| EPS, 1Y Change | +18.47% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$3.02 | |
| EPS Estimate | N/A | -$4.22 |
| EPS Est. Change | N/A | -39.50% |
| Revenue | $0.00 | |
| Revenue Estimate | N/A | $5.74M |
| Revenue Est. Change | N/A | - |
| Current Price | $123.63 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$3.71 | - | |
| -$3.05 | -$3.02 | +0.82% | |
| -$4.22 | N/A | -39.50% | |
| -$3.28 | N/A | -8.35% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.93M | $0.00 | -100.00% | |
| $8.16M | $0.00 | -100.00% | |
| $5.74M | N/A | - | |
| $35.83M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +1,884.43% | |
| Price, 3Y | - | |
| Market Cap, 1Y | +2,356.65% | |
| Market Cap, 3Y | - | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | +18.47% | |
| EPS, 3Y | -3.65% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $123.63 | |
| SMA 200 | $64.89 | |
| SMA 200 vs Price | -47.51% | |
| SMA 50 | $121.00 | |
| SMA 50 vs Price | -2.13% | |
| Beta | 2.25 | |
| ATR | $8.61 | |
| 14-Day RSI | 51.53 | |
| 10-Day Volatility | 67.71% | |
| 1-Year Volatility | 590.54% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$3.02 | |
| Gross Profit | -$1.19M | |
| Gross Margin | - | |
| Operating Profit | -$187.23M | |
| Operating Margin | - | |
| Net Income | -$190.64M | |
| Net Margin | - | |
| EBITDA | -$176.11M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 2.37 | |
| Current Ratio | 1.82 | |
| Quick Ratio | 1.84 | |
| Interest Coverage | -13.18 | |
| - | ||
| Altman Z-Score | 28.83 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | - | |
| PB Ratio | 16.14 | |
| EV/EBITDA | -45.18 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $42.23M | |
| Cash & Equivalents | $150.07M | |
| Total Assets | $212.51M | |
| Current Assets | $177.60M | |
| Total Liabilities | $170.49M | |
| Current Liabilities | $96.60M | |
| Total Debt | $99.61M | |
| Short Term Debt | $45.32M | |
| Accounts Payable | $45.60M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $187.23M | |
| Operating Expenses | $187.23M | |
| Cost Of Goods Sold | $1.19M | |
| SG&A | $0.00 | |
| D&A | $1.19M | |
| Interest Expense | $13.45M | |
| Income Tax | $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$166.14M | |
| CFI | $8.20M | |
| CFF | $38.84M | |
| Capex | $695.50K | |
| Free Cash Flow | -$166.83M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Morgan Stanley | → | |
| BTIG | → | |
| Citizens | → | |
| Truist Securities | ||
| Wolfe Research | ||
| Barclays | ||
| Guggenheim | → | |
| BTIG | → | |
| JMP Securities | → | |
| Morgan Stanley | → |
Analyst sentiment
Institutional ownership
Screeners with ABVX
FAQ
What is the ticker symbol for ABIVAX Société Anonyme?
The ticker symbol for ABIVAX Société Anonyme is NASDAQ:ABVX
Does ABIVAX Société Anonyme pay dividends?
No, ABIVAX Société Anonyme does not pay dividends
What sector is ABIVAX Société Anonyme in?
ABIVAX Société Anonyme is in the Healthcare sector
What industry is ABIVAX Société Anonyme in?
ABIVAX Société Anonyme is in the Biotechnology industry
What country is ABIVAX Société Anonyme based in?
ABIVAX Société Anonyme is headquartered in France
When did ABIVAX Société Anonyme go public?
ABIVAX Société Anonyme initial public offering (IPO) was on October 20, 2023
Is ABIVAX Société Anonyme in the S&P 500?
No, ABIVAX Société Anonyme is not included in the S&P 500 index
Is ABIVAX Société Anonyme in the NASDAQ 100?
No, ABIVAX Société Anonyme is not included in the NASDAQ 100 index
Is ABIVAX Société Anonyme in the Dow Jones?
No, ABIVAX Société Anonyme is not included in the Dow Jones index
When was ABIVAX Société Anonyme last earnings report?
ABIVAX Société Anonyme's most recent earnings report was on August 11, 2025
When does ABIVAX Société Anonyme report earnings?
The date for ABIVAX Société Anonyme's next earnings report has not been announced yet
Data Sources & References
- ABVX Official Website www.abivax.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1956827/000195682725000010/0001956827-25-000010-index.htm
- ABVX Profile on Yahoo Finance finance.yahoo.com/quote/ABVX
- ABVX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abvx